ThirtyFiveBio reposted this
I'm excited to be attending Investival Showcase 2024, taking place on 18 November 2024 at Tobacco Dock. Please reach out to me over LinkedIn or using the Partnering system to discuss ThirtyFiveBio's discovery of and plans to development GPR35 antagonists for treatment of serious inflammatory diseases of the GI tract, including colitis and cancer. GPR35 is a novel genetically-validated target, and modulation promises to target underlying and unresolved epithelial dysfunction in patients. Join us to connect life science & healthcare executives with capital and kick off Europe's biggest dedicated healthcare investment week #ThirtyFiveBio #GPR35 #Investival https://lnkd.in/eCZS6ktr Investival Showcase
